We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Notes Possible Risk for Pregnant Women Taking Lamictal
FDA Notes Possible Risk for Pregnant Women Taking Lamictal
October 3, 2006
The FDA said Sept. 29 that babies exposed during the first three months of pregnancy to the drug Lamictal, which is used to treat epileptic seizures and bipolar disorder, may have a higher chance of being born with a cleft lip or cleft palate.